165 related articles for article (PubMed ID: 9669206)
21. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
[TBL] [Abstract][Full Text] [Related]
22. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes.
Silva CL; Cruz HN; Violante FA; Cordeiro RS; Martins MA; Noël F
Biochem Pharmacol; 1996 Jan; 51(2):193-6. PubMed ID: 8615889
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages.
Centemeri C; Colli S; Tosarello D; Ciceri P; Nicosia S
Biochem Pharmacol; 1999 Feb; 57(3):263-71. PubMed ID: 9890553
[TBL] [Abstract][Full Text] [Related]
26. Effect of serine proteinase inhibitors on intracellular free calcium rise in human polymorphonuclear leukocytes after stimulation with receptor agonists.
Nowak D; Król M; Białasiewicz P
Arch Immunol Ther Exp (Warsz); 1998; 46(2):121-6. PubMed ID: 9613710
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
Hilger RA; Köller M; König W
Inflammation; 1996 Feb; 20(1):57-70. PubMed ID: 8926049
[TBL] [Abstract][Full Text] [Related]
29. Novel action of lignans isolated from Hernandia nymphaeifolia on Ca2+ signaling in human neutrophils.
Chao YY; Su W; Jan CR; Ko YC; Chen JJ; Cheng JS; Liu CP; Lo YK; Chou KJ; Lee KC; Chen WC; Chen IS
Arch Toxicol; 2002 Jan; 75(11-12):695-702. PubMed ID: 11876502
[TBL] [Abstract][Full Text] [Related]
30. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
31. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
Jan CR; Chao YY
Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of intracellular free calcium increases by platelet-activating factor in HT29 colon carcinoma cells. Spectrofluorimetric and preliminary spatio-temporal analysis using confocal laser scanning fluorescence imaging microscopy.
Lohmeyer M; McNaughton L; Hunt SP; Workman P
Biochem Pharmacol; 1994 Mar; 47(6):975-85. PubMed ID: 8147917
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
34. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils.
Rossi AG; McMillan RM; MacIntyre DE
Agents Actions; 1988 Jul; 24(3-4):272-82. PubMed ID: 2845744
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
[TBL] [Abstract][Full Text] [Related]
36. Novel effect of Y-24180, a presumed specific platelet-activating factor receptor antagonist, on Ca2+ levels and growth of human osteosarcoma cells.
Jan CR; Chao YY
Pharmacol Res; 2005 Mar; 51(3):189-95. PubMed ID: 15661567
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
Bauldry SA; Wooten RE
Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
[TBL] [Abstract][Full Text] [Related]
39. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.
Shindo K; Koide K; Fukumura M
Thorax; 1997 Dec; 52(12):1024-9. PubMed ID: 9516893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
